Newsroom

A study by MLPS reveals proposed changes in patient medication information delivery could cost the EU up to €3.5 billion annually. The bipartisan Patients’ Right to Know Their Medication Act aims to protect access to printed PMI and has 14 bipartisan cosponsors. The Pharmaceutical Printed Literature Association advocates for patient safety and accessibility. Read More

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the Patients’ Right to Know Their Medication Act (H.R. 1173), with strong bipartisan Congressional support. The bill aims to ensure patients have access to printed Patient Medication Information (PMI) with FDA-approved content, resisting a proposed FDA rule to digitize PMI, which could hinder access for rural… Read More

The Pharmaceutical Printed Literature Association (PPLA) opposes the FDA’s rule lowering access to printed Patient Medication Information (PMI) due to its potential negative impact. The rule would shift PMI to digital format, raising concerns about access and cost. The PPLA advocates for the bipartisan Patients’ Right to Know Their Medication Act to standardize PMI based… Read More

The Pharmaceutical Printed Literature Association (PPLA) hails Congresswoman Perez for supporting the bipartisan Patients’ Right to Know Their Medication Act, which aims to standardize medication information, reduce confusion, and improve patient adherence. The act is co-sponsored by several representatives and supported by the PPLA to ensure clear, accessible medication information for all Americans. Read More

The Pharmaceutical Printed Literature Association (PPLA) praises Congresswoman Peltola for supporting the Patients’ Right to Know Their Medication Act, aiming to standardize medication information and reduce medication-related issues. The lack of standardization causes confusion and non-adherence, leading to adverse events and high costs. The bipartisan bill aims to improve patient safety and minimize risks. Read More